New York, September 14, 2015 -- Moody's Investors Service assigned a provisional (P)Baa2 rating to the proposed note offering of St. Jude Medical, Inc. (St. Jude). At the same time, Moody's assigned a (P)Baa2 to the company's newly established bank credit facilities. Moody's expects the rating outlook to be negative. Proceeds from the note offering and bank borrowings will largely be used to fund the $3.4 billion acquisition (net of acquired cash) of Thoratec Corporation, which management expects to close in the fourth quarter of 2015.
Vollständigen Artikel bei Moodys lesen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.